Response: Alzheimer’s disease (AD)
I agree with my classmate piece of writing, focusing on Alzheimer’s condition. It not only explains the root cause for AD but also discusses extensive researches in stem cell therapy that will one day reverse the progression of AD. Primarily, the paper denotes primary factors necessitating Alzheimer’s disease, and that includes the tau protein. Alzheimer’s disease, an ordinary form of dementia, has additional elements causing it which involve amyloid-beta (AB) plaques and the APOE4 gene. The paper goes further by describing how the tau protein, amyloid-beta (AB) plaques and APOE4 gene develops. An amyloid-beta plaque, for instance, comes from amyloid precursor proteins generated from secretase enzymes. On the other hand, AB plaque aggregates outside neutrons which facilitate impairment of neural synapses. Lastly, tau protein forms intracellular neurofibrillary tangles.
Indeed, the paper is unique in its ability to denoting their factors mentioned above’ knack for finding treatments. The writing furthermore, incorporates Duncan and Valenzuela’s “Alzheimer’s disease, dementia and stem cell therapy” article in bringing the point home. It defines the various approaches used to get the cure for AD, such as the involvement of different stem cells. They include embryonic neural stem cells, stem cells and mesenchymal stems cells. Besides, the writing emphasizes if one day, a successful stem cell therapy is found, then the services should be made available for all the patients. And as successful stem cell therapy would lead to the promotion of memory-associated regions in the brain to undergo neurogenesis, the services should remain affordable. And as we all are aware that the treatment can at times be costly, it is crucial to involve the insurance cover to stand for the cost incorporated. It is only the remaining cost that should be made affordable for the patient or their family members paying for the bill.